NASDAQ undervalued ranking
Ranked by the Acquirer's Multiple strategy. Lower valuation ranks higher. · Healthcare
Data as of: 2026-10-30 · end-of-day, not real-time
Information & education only — not investment advice or a guarantee of returns.
Best Undervalued NASDAQ Stocks (2026) →
Best Balanced NASDAQ Stocks (2026) →
💡 Preset screens
7 stocks · 4 value-trap stocks hidden
Return periodtrading days (holidays excluded)
Sort
1Gilead Sciences Inc.GILD NASDAQ · HealthcareP/E–44.5
Mkt Cap
$211.8B
P/E
–
P/B
9.3
1M
+17.9%
2Amgen Inc.AMGN NASDAQ · HealthcareP/E28.938.8
Mkt Cap
$251.9B
P/E
28.9
P/B
21.6
1M
+15.6%
3Medline Inc.MDLN NASDAQ · HealthcareP/E80.335.9
Mkt Cap
$43.2B
P/E
80.3
P/B
2.4
1M
-9.8%
4Regeneron Pharmaceuticals Inc.REGN NASDAQ · HealthcareP/E22.934.4①
💊 Bio/vaccine
Mkt Cap
$95.5B
P/E
22.9
P/B
3.0
1M
+26.2%
5Vertex Pharmaceuticals IncorporatedVRTX NASDAQ · HealthcareP/E32.521.2①
Mkt Cap
$141.7B
P/E
32.5
P/B
7.0
1M
+10.7%
6IDEXX Laboratories Inc.IDXX NASDAQ · HealthcareP/E38.720.2①
Mkt Cap
$43.4B
P/E
38.7
P/B
27.0
1M
+6.3%
7argenx SEARGX NASDAQ · HealthcareP/E30.9–①
Mkt Cap
$56.1B
P/E
30.9
P/B
165.8
1M
-2.9%